8:00 am Registration & Morning Refreshments
8:50 am Chair’s Opening Remarks
Securing Bioefficacy & Safety Data to to Streamline Preclinical Translation & Safeguard Regulatory Approval
9:00 am Demonstrating Proof of Bioefficacy to Streamline Preclinical to Clinical
Synopsis
- Discussing the rationale behind using preclinical models and alternative design of experiment routes to optimally demonstrate bioefficacy
- Decoding the translation from preclinical to clinical growth studies to understand how to portray growth within experimental design limitations
- Adopting a multifactorial approach to support the business of proving bioefficacy
9:30 am Case Study: Tapping into the Chinese Market to Inspire Formula Commercialization & Regulatory Strategy
Synopsis
- Shedding light on the current demographic situation to understand market status and commercial positioning
- Navigating the complex infant formula registration journey from trial production to commercialization to pin-point successes for business strategies within the Chinese market
- Eradicating regulatory bottlenecks – from obstacles to approval
10:00 am Navigating Pre-Submission Meetings to Propel Product Development Plans & Future Success
Synopsis
- Clarifying pre-submission requirements in preparation for meetings to streamline the submission process
- Engaging with regulators from early stages to pin-point areas of risk and mitigate accordingly
- Building relationships with regulators via pre-submission meetings to enhance open communication and spark positive collaboration
10:30 am Speed Networking & Morning Coffee Break
Specializing Functionality via Robust Measures to Enhance Quality Profiles
11:30 am Assessing the Scope & Progress of Novel Bioactives to Move Closer Towards Human Milk & Direct Future Focuses
Synopsis
- Discussing latest scientific updates on MFGM’s in infant formula to understand current and future opportunities
- Delving into human milk oligosaccharides and galacto-oligosaccharides to navigate complexities
- Providing an in-depth analysis of Bovine IgG to understand its usage in infant formula
12:00 pm Evolving Functionality to Meet Infant Formula Requirements Regarding Nutritional Profile & Structures Bridging the Gap to Human Milk
Synopsis
- Front-loading ingredient-to-formula compatibility to ensure function is retained for desired physiological and cognitive effects
- Analyzing and assessing functional parameters in alignment with human milk functionality to hone in on desired characteristics
- Bridging closely towards milk-based flavours and functions to support humanization
12:30 pm Networking Lunch
Leveraging Commercial Factors to Inform Formulae Personalization & Influence Perception
1:30 pm Advocating Nutrition Education to Resonate Closely with Your Market in Light of Commercialization
Synopsis
- Depicting language nuances and marketing strategy to closely speak to your scientifically driven market for trust-building
- Leveraging nutrition education and market resonance to identify launch location within timeframes
- Assessing efficacy claim allowance globally to inform launch location and business gameplan
2:00 pm Roundtable Discussion: Addressing the Future Roadmap for Bioactive Ingredient Applications to Drive Technical & Commercial Expansion
Synopsis
- Pin-pointing commercial successes and failures beyond standard bioactives to engage consumers and external partners
- Discussing commercial entry approaches for formula products to secure consumer attraction
- Identifying future targets for formula ingredients to shine light on next steps for industry
Optimizing Translation & Communication to Streamline from Science to End-Users
2:45 pm Delving into Translational Science & To Effectively Communicate the Value of Your Formula & Secure Engagement
Synopsis
- Demonstrating beneficial effects and value added from formula to consumers to bridge the gap between scientific approach and understanding
- Streamlining from the clinic to the end-user in order to effectively understand requirements and communicate efficacy
- Understanding how to prioritize which beneficial effects to communicate in order to support nutritional value added
3:15 pm Afternoon Break
4:00 pm Translating Key Clinical Trial Findings to Support Nutritional & Safety Claims
Synopsis
- Discussing considerations for design and analysis of a clinical trial for translation of outcomes into impactful claims
- Utilizing clinical biomarkers and parent-reported symptoms to explore the safety, efficacy, and health impact of an infant formula
- Understanding the value creation of infant formula trials beyond individual ingredient innovation
4:30 pm Understanding Human Milk as a Biological System to Discuss Implications for Infant Feeding & Breastmilk Ecology: Genesis of Infant Nutrition: “BEGIN”
Synopsis
- Addressing unanswered questions regarding chronobiology of human milk to understand infant implications
- Understanding translational implications regarding infant feeding and human milk biology
- Discussing donor milk claims and effects in relation to pre-term infants to address where current requirements lie